Research and Markets (http://www.researchandmarkets.com/research/cfb25d/2009_cro_quality_b) has announced the addition of the "2009 CRO Quality Benchmarking Study - CRO Selection for Biotechnology Companies" report to their offering.
This is a substantial study based on interviews with 44 biotechnology company representatives, rating 130 unique projects with CROs. Respondents graded 10 prominent service providers across 18 important capabilities that affect provider selection and delivery quality. The report contains 139 pages, including 138 charts and graphs, and in-depth analysis not previously available to the industry.
This study - designed, executed and analyzed by research professionals from the pharma services industry - is the first ever "Consumer Reports" style guide to buying and delivering quality product development services.
Service buyers can rely on this report to substantially inform their selection of development partners that best fit their unique needs.
Service providers can rely on this report to provide them with clear service enhancement recommendations and opportunities to differentiate themselves from the crowded market of CROs.
Key Topics Covered:
Executive Summary
Study Methodology
Market Dynamics and Selection Criteria
Service Provider Quality, Performance, and Perceptions
Service Variability IndexTM (SVI)
Service Provider Differentiation
Appendix of Charts and Graphs
About Industry Standard Research
For more information visit http://www.researchandmarkets.com/research/cfb25d/2009_cro_quality_b
|